Upcoming IPO: Indira IVF Refiles Draft Papers For IPO Via Confidential Route
EQT‑backed fertility services provider Indira IVF Hospital Ltd has confidentially refiled its Draft Red Herring Prospectus (DRHP) with SEBI, according to a Bloomberg report. The confidential route allows companies to submit their DRHP to SEBI without immediate public disclosure.
Indira IVF had initially filed in February 2025 but withdrew in March after a Bollywood biopic on founder Dr Ajay Murdia raised concerns of potential indirect promotion, though the company insisted the withdrawal was for “commercial considerations”, not due to SEBI instructions.
According to Bloomberg, the issue could be ₹3,500 crore ($408 million), with no fresh equity; instead, existing shareholders (EQT and founding family members) are looking to offload shares.
The confidential route, available since 2022, has been used by firms like Groww, Swiggy, Vishal Mega Mart, Meesho, Tata Capital, Shiprocket, boAt, and PhysicsWallah.
Click here to explore other Upcoming IPOs
Click here to check out newly Listed IPOs
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here